Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Fig. 1

Study flow-chart. The graph gives information about the patient flow from baseline / end of the EDITA study until the last follow-up in the EDITA-ON study. Exercise PH: Δ (mPAP/cardiac output) > 3 mmHg/l/min, mPAP: mean pulmonary arterial pressure, PAH: pulmonary arterial hypertension, PAWP: pulmonary arterial wedge pressure, PH: pulmonary hypertension, RHC: right heart catheterization, TPG: transpulmonary gradient. *early termination patients from EDITA trial that continued follow-up (EDITA-ON). without treatment: from placebo group n = 2, from ambrisentan group n = 1

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us